Adial Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
GLEN ALLEN, Va., May 15, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”),…
23,210€
0,78%
Echtzeit-Aktienkurs Acadia Pharmaceuticals Inc.
Bid:
Ask:
Nachrichten zur Acadia Pharmaceuticals Inc. Aktie
NRx Pharmaceuticals, Inc. (NRXP) Q1 2024 Earnings Call Transcript
…
ACADIA Pharmaceuticals Inc. (ACAD) Q1 2024 Earnings Call Transcript
…
ACADIA Pharmaceuticals Inc. 2024 Q1 - Results - Earnings Call Presentation
…
Biotech Stock Roundup: AMLX, ACAD Down on Study Data, MRNA, RGLS Gain on Updates & More
Amylyx Pharmaceuticals (AMLX) and Acadia Pharmaceuticals (ACAD) plunged on failure of studies.…
Acadia Pharmaceuticals: Post Pimavanserin Study Setback Selloff May Continue
…
Adial Pharmaceuticals Announces Exercise of Warrants for $3.5 Million Gross Proceeds
CHARLOTTESVILLE, Va., March 01, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a…
Acadia Pharmaceuticals: New Daybue Drug Already Showing Signs Of Slowing
…
Acadia Pharmaceuticals: Daybue Growth Concerns, Important Data Readout Coming
…
ACADIA Pharmaceuticals Inc. (ACAD) Q4 2023 Earnings Call Transcript
…
ACADIA Pharmaceuticals Inc. 2023 Q4 - Results - Earnings Call Presentation
…